Michael Scolarici

Michael Scolarici

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2021 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
MSMichael Scolarici
Michael Scolarici
MJMargaret Jorgenson
Margaret Jorgenson
CSChristopher Saddler
Christopher Saddler
JSJeannina Smith
Jeannina Smith
Invasive fungal infections (IFIs) are one of the most feared complications associated with liver transplantation, with high rates of morbidity and mortality. We discuss the most common invasive fungal infections in the setting of liver transplant, including Candida, Aspergillus, and Cryptococcal infections, and some less frequent but devastating mold infections. Further, we evaluate the use of prophylaxis to prevent invasive fungal infection in this population as a promising mechanism to reduce risks to patients after liver transplant.

27 April 2022 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
MSMichael Scolarici
Michael Scolarici
CKColeton King
Coleton King
ASAlana Sterkel
Alana Sterkel
JSJeannina Smith
Jeannina Smith
GGGregory Gauthier
Gregory Gauthier
CSChristopher Saddler
Christopher Saddler
Blastomyces spp, the etiologic agents of blastomycosis, are endemic dimorphic fungi that require prolonged antifungal therapy, which can be complicated by adverse drug effects. Isavuconazonium sulphate (ISA) is a triazole with in vitro and in vivo activity against Blastomyces spp, but there is a paucity of clinical data supporting its use for treatment of blastomycosis. This retrospective case series identified 14 patients with blastomycosis at least partially treated with ISA at the University of Wisconsin between 2015 and 2019. Treatment duration and outcomes were documented. In addition, 29 clinical isolates of Blastomyces spp between 2004 and 2017 were tested for minimum inhibitory concentrations against ISA and other antifungals. Fourteen patients were treated with a median of 255 days of ISA accounting for 68% of total therapy. Half (7 of 14) of the patients were immunocompromised, 11 of 14 (79%) were proven cases of blastomycosis, 7 of 14 (50%) had central nervous system (CNS) involvement, and 11 of 14 (79%) were cured. Antifungal susceptibility testing showed a consistently low minimum inhibitory concentration to ISA ≤ 0.015 mcg/mL. This case series supports the efficacy and safety for ISA in the treatment of blastomycosis with or without CNS disseminated, especially when alternative triazoles cannot be used.

1 September 2014 in Clinical Therapeutics
Verified
Journal Article
Closed access
SMScott T. Micek
Scott T. Micek
HAHeather Arnold
Heather Arnold
PJPaul Juang
Paul Juang
NHNicholas Hampton
Nicholas Hampton
MMMatthew McKenzie
Matthew McKenzie
MKMarin H Kollef
Marin H Kollef

19 November 2025 in Transplant Infectious Disease
Verified
Journal Article
Open access
MSMichael Scolarici
Michael Scolarici
JTJessica Tischendorf
Jessica Tischendorf
RFRachel Filipiak
Rachel Filipiak
LDLara Danziger‐Isakov
Lara Danziger‐Isakov
BHBenjamin Hanisch
Benjamin Hanisch
CSChristopher Saddler
Christopher Saddler
Background: Transplant infectious disease (TID) training is not accredited by the Accreditation Council for Graduate Medical Education (ACGME) and is not standardized. Prior surveys of the training landscape in TID have focused on fellow responses; we sought description of programs from program directors and coordinators. Methods: Along with the American Society of Transplantation (AST) Infectious Disease Community of Practice (IDCOP), we administered a survey to adult and pediatric ID training programs focusing on the structure, funding, curriculum, and outcomes of ID fellows participating in TID fellowships and tracks. This manuscript is a work product of the American Society of Transplantation's Education Committee. Results: We had 42 respondents representing 15 adult TID fellowships, 12 adult TID tracks, 4 pediatric TID fellowships, and 6 pediatric TID tracks. Adult TID fellowships required slightly more inpatient weeks than adult TID tracks: 26 versus 24 ( p = 0.03). A majority of adult TID fellowships 10/14 (71%) rely on multiple sources of funding for their programs. A total of 67% of adult and 75% of pediatric TID fellowships have didactic curriculum, distinct from their general fellowship, and 53% of adult TID fellowships and no pediatric TID fellowships have distinct core competencies to evaluate TID fellows. Most TID fellows are pursuing TID‐focused clinical careers. Conclusions: Substantial heterogeneity exists among TID fellowships, and between fellowships and tracks. Future directions include updating prior guidance for adult and pediatric TID tracks and fellowships on curriculum, core competencies, and baseline requirements to ensure adequate competency in the care of these vulnerable patients.

18 May 2024 in Transplant Infectious Disease
Verified
Journal Article
Open access
MSMichael Scolarici
Michael Scolarici
LBLeigh R. Berman
Leigh R. Berman
NCNatalie Callander
Natalie Callander
JSJeannina Smith
Jeannina Smith
CSChristopher Saddler
Christopher Saddler
Background: Infective endocarditis (IE) is a serious complication of bloodstream infections (BSIs) that occurs at variable rates depending on the pathogen and clinical setting. There is a paucity of data describing the risk of IE in patients with hematologic malignancy who develop bacteremia while neutropenic.Methods: Adult patients on the hematology ward from January 2018 to December 2020 with hematologic malignancy and bacteremia were evaluated retrospectively for endocarditis by applying the 2023 Duke‐ISCVID criteria. Charts of possible cases were evaluated 90 days after the initial BSI for new infectious complications that could indicate missed IE. Descriptive statistics compared patients admitted for hematopoietic stem cell transplantation (HSCT) to those admitted for alternative reasons (non‐HSCT).Results: Among the 1005 positive blood cultures initially identified, there were 66 episodes in 65 patients with hematologic malignancy and at least grade 3 neutropenia for a mean duration of 11.4 days during their admission. Transthoracic echocardiography (TTE) was performed in 34.8% of BSIs, and transesophageal echocardiography (TEE) in 6.1%. There were no new infectious complications in possible cases 90 days after their initial BSI. No cases of endocarditis were identified.Conclusions: Endocarditis is rare amongst patients with hematologic malignancy, bacteremia, and neutropenia, and no cases were identified in this cohort. The use of routine TTE in this setting seems unwarranted, and the addition of TEE is unlikely to improve patient‐centered outcomes. image

21 February 2025 in CMI Communications
Verified
Journal Article
Open access
MSMichael Scolarici
Michael Scolarici
JSJeannina Smith
Jeannina Smith